Feedback / Questions
Galafold (migalastat) - Amicus
https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/paper/ispor-europe-2025/poster-session-1-2/budget-impact-analysis-of-migalastat-incorporation-vs-enzyme-replacement-therapies-for-fabry-disease-validation-of-a-cost-assessment-tool-in-brazilian-private-healthcare-system
Joao Paulo Dos Reis Neto, PhD, MD 1; JULIANA BUSCH, MD 2.
Nov 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next